Menu Search
Equities

Golden Throat Holdings Group Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
6896:HKG

Golden Throat Holdings Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)3.14
  • Today's Change-0.04 / -1.26%
  • Shares traded367.50k
  • 1 Year change-2.18%
  • Beta0.1823
Data delayed at least 15 minutes, as of Feb 20 2026 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Golden Throat Holdings Group Co Ltd grew revenues 23.26% from 961.38m to 1.19bn while net income improved 27.37% from 250.16m to 318.63m.
Gross margin76.42%
Net profit margin27.37%
Operating margin39.34%
Return on assets12.78%
Return on equity21.53%
Return on investment21.02%
More ▼

Cash flow in CNYView more

In 2024, Golden Throat Holdings Group Co Ltd increased its cash reserves by 9.37%, or 92.40m. The company earned 475.87m from its operations for a Cash Flow Margin of 40.16%. In addition the company used 41.61m on investing activities and also paid 335.18m in financing cash flows.
Cash flow per share0.4611
Price/Cash flow per share6.90
Book value per share1.85
Tangible book value per share1.85
More ▼

Balance sheet in CNYView more

Golden Throat Holdings Group Co Ltd appears to have a strong balance sheet and has grown its cash reserves consistently over the last four years to total 1.04bn. In fact, 0.44% of the value of Golden Throat Holdings Group Co Ltd shares can be attributed to this cash.
Current ratio1.87
Quick ratio1.73
Total debt/total equity0.5664
Total debt/total capital0.3616
More ▼

Growth rates in CNY

Year on year, growth in dividends per share fell -13.85% while earnings per share excluding extraordinary items rose 27.37%. Additionally when measured on a five year annualized basis, dividend per share growth is above the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)15.03%
Div growth rate (5 year)34.38%
Payout ratio (TTM)127.68%
EPS growth(5 years)13.71
EPS (TTM) vs
TTM 1 year ago		2.25
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.